Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01BUS
|
||||
Former ID |
DIB012344
|
||||
Drug Name |
CA9-ADC
|
||||
Synonyms |
MN-IC; CA IX inhibitor (solid tumor, ADC, HuCAL), MorphoSys/Bayer Schering Pharma; Carbonic anhydrase IX inhibitor (solid tumor, antibody-drug conjugate, HuCAL), MorphoSys/Bayer Schering Pharma
|
||||
Drug Type |
Antibody
|
||||
Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Discontinued in Phase 1 | [549015] | ||
Company |
MorphoSys AG
|
||||
Target and Pathway | |||||
Target(s) | Carbonic anhydrase IX | Target Info | [531730] | ||
KEGG Pathway | Nitrogen metabolism | ||||
Pathway Interaction Database | HIF-1-alpha transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.